NCT06146010 2026-04-08
Non Interventional German Leptomeningeal Disease Register
University Hospital Tuebingen
Recruiting
Clinical Trials
13 trialsNCT03025256 2026-04-02
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05809752 2026-04-01
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Recruiting
NCT02422641 2026-03-23
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT07476781 2026-03-17
CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases
Sunnybrook Health Sciences Centre
Phase NA Recruiting
NCT04988009 2026-03-05
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
M.D. Anderson Cancer Center
Recruiting
NCT06016387 2026-02-23
Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study
Sunnybrook Health Sciences Centre
Phase 2 Recruiting
NCT04588545 2026-02-09
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Recruiting
NCT05800275 2025-11-18
ETIC-LM
UNICANCER
Phase 2 Recruiting
NCT06933199 2025-05-04
NeoSTROBE
University Hospital Ostrava
Phase NA Recruiting
NCT05112549 2025-04-03
IT-PD1
University Hospital Tuebingen
Phase 1 Recruiting
NCT05257967 2025-02-11
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease
British Columbia Cancer Agency
Phase NA Recruiting
NCT06417710 2024-05-16
NANO-LM
University of Zurich
Recruiting